We were thus able to conclude that age - related cognitive decline is accentuated by chemotherapy, providing basis for questioning
the place of adjuvant chemotherapy in this elderly patient population.
There was no difference in lactate dehydrogenase, the number
of metastatic sites, prior
adjuvant therapy, primary in
place at initiation
of therapy, or intent
of treatment across the cohorts for right - compared with left - sided tumors.